Cargando…
Navigating through the Lipid Metabolism Maze: Diagnosis and Prognosis Metabolites of Hepatocellular Carcinoma versus Compensated Cirrhosis
(1) Background: The pursuit of finding biomarkers for the diagnosis and prognosis of hepatocellular carcinoma (HCC) has never been so paramount in the days of personalized medicine. The main objective of our study is to identify new biomarkers for diagnosing HCC, and to identify which patients are a...
Autores principales: | Nenu, Iuliana, Stefanescu, Horia, Procopet, Bogdan, Sparchez, Zeno, Minciuna, Iulia, Mocan, Tudor, Leucuta, Daniel, Morar, Corina, Grigorescu, Mircea, Filip, Gabriela Adriana, Socaciu, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910918/ https://www.ncbi.nlm.nih.gov/pubmed/35268381 http://dx.doi.org/10.3390/jcm11051292 |
Ejemplares similares
-
Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?
por: Sparchez, Zeno, et al.
Publicado: (2021) -
Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications
por: Spârchez, Zeno, et al.
Publicado: (2023) -
Percutaneous ultrasound guided PEG-coated gold nanoparticles enhanced radiofrequency ablation in liver
por: Mocan, Tudor, et al.
Publicado: (2021) -
Is Fasting Good When One Is at Risk of Liver Cancer?
por: Minciuna, Iulia, et al.
Publicado: (2022) -
Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?
por: Mocan, Tudor, et al.
Publicado: (2021)